Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001)
Clinical trial NCT02553499 · TERMINATED
Trial details
- NCT number
- NCT02553499
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-12
- Primary completion
- 2018-10-17
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.